Salmonella spp. are the etiologic agents of salmonellosis, a worldwide spread zoonoses causing foodborne outbreaks and clinical diseases. By serological identification, Salmonella enterica subsp. enterica serotype 1,4,[5],12:i:-accounted for 8.8% of human and 1.6% of nonhuman Salmonella strains isolated in São Paulo State, during 1991-2000. A total of 28.6% of them amplified a fragment corresponding to H:1,2 (flagellar phase two) through PCR analysis and were further assigned as S. Typhimurium. Antimicrobial resistance was detected in 36.3% of the 369 PCR-negative strains tested, including the multiresistance to ampicillin, chloramphenicol, sulfonamides, tetracycline, and streptomycin.
Salmonella spp. strains are the etiologic agents of salmonellosis, a zoonotic disease worldwide spread, and/or enteric fevers depending on the serotypes involved. Salmonella serotypes have been traditionally defined through serological identification of somatic (O) and flagellar (H) factor antigens present in the bacterial cell. Most Salmonella strains are motile by peritrichous flagella and an important characteristic of the genus is the presence of two different flagellin genes on the bacterial chromosome, fliC and fljB (formerly H1 and H2), which expression is done by a system called "phase variation" 8, 14 . The great majority of the 2,501 Salmonella serotypes listed in the Kauffmann-White scheme 10 expresses alternatively both genes (phase one and phase two), being then called biphasic. The remaining serotypes displaying only one flagellar phase are designated monophasic. , and in the U.S.A. In São Paulo, Brazil, S. I 1,4, [5] ,12:i:-has been detected in samples of human and nonhuman origins through the last decades, with an increasing of up to five times in the 90´s, being particularly associated with human foodborne outbreaks and septicemia cases 11, 12, 13 . Besides that, S. I 1,4, [5] ,12:i:-has been found among the top five Salmonella serotypes isolated from human infections in our area, together with S. Enteritidis and S. Typhimurium. This study reports the "multiplex PCR" identification of S. I 1,4, [5] ,12:i:-and its frequency and antimicrobial resistance patterns, providing baseline for further characterization.
Salmonella enterica
From January 1991 through December 2000, 389 (8.8%) out of 4,426 Salmonella human strains (including 61.0% from feces and 25.0% from blood) and 128 (1.6%) out of 7,827 nonhuman ones (mostly from foodstuffs and animals) were identified as S. I 1,4, [5] ,12:i:-at the Enteropathogens Laboratory, Instituto Adolfo Lutz, São Paulo. Those strains were isolated in different cities of São Paulo State. Isolation and identification of strains at the genus level were performed as described by EWING 6 . Salmonella subspecies determination and serotyping were carried out according to POPOFF 10 . Every somatic and flagellar antiserum used for Salmonella serotyping has been produced and maintained by this Enteropathogens Laboratory.
Those 517 strains were firstly assigned as S. I 1,4, [5] ,12:i:-by slide agglutination method with polyclonal antisera and stored in agar slant at room temperature. Afterwards, they were submitted to the "multiplex PCR" method described by ECHEITA & USERA 3 in order to detect the gene encoding for the flagellar phase two in the H1 antigenic complex (H:1,2, H:1,5, H:1,6, H:1,7). One hundred and forty-eight (28.6%) strains amplified the 394 bp-fragment specific for H:1,2 being, therefore, assigned as S. Typhimurium. These results indicate that the undetected flagellar phase two during the serologic identification is likely to be due to the low level of bacterial cells expressing this antigen. Thus, the "Multiplex PCR" proved to be a useful and complementary tool for the classical serological identification of S. The results showed that all strains were susceptible to aztreonam, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, and imipenem. Table  1 demonstrates that 8% of human and 5% of nonhuman strains were susceptible to all antimicrobials tested. A total of 208 (56.3%) strains (55% human and 62.5% nonhuman) presented intermediate resistance, mostly to tetracycline (91%) and streptomycin (64%). One hundred and thirty-four (36.3%) strains (37% human and 31% nonhuman) exhibited resistance to one up to 13 antimicrobial agents, distributed to 30 resistance patterns (Table 1) . Such resistance was mostly to tetracycline (68%), Table 1 Antimicrobial susceptibility patterns of the 369 S. Although no strain was resistant to ciprofloxacin, six strains presented resistance to nalidixic acid. Approximately 90% of the human strains isolated from blood displayed some resistance or decreased susceptibility to the antimicrobials suggesting a special concern with such strains. Multiresistance was found in the same level (5%) for both human and nonhuman strains. No increase in antibiotic resistance was observed throughout the period under study.
Further studies on phenotypic and molecular characterization of S. I 1,4, [5] ,12:i:-and S. Typhimurium strains are in progress in this laboratory by some of us. Data obtained from those studies will be compared in order to confirm the genetic relationship between these two serotypes. 
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